Search results
Results from the WOW.Com Content Network
According to the Center for Public Integrity, from January 2005 through June 2006 alone, the pharmaceutical industry spent approximately $182 million on federal lobbying in the United States. [2] In 2005, the industry had 1,274 registered lobbyists in Washington, D.C. [ 3 ]
Despite the role that patents have played in maintaining higher drug costs for public health programs across Africa, the organization worked to minimize the effect of the Doha Declaration, which said that TRIPS should not prevent countries from dealing with public health crises and allowed for compulsory licenses.
The collapse of the deal is the latest example of how the pharmaceutical industry is battling the US government on a number of fronts, including the White House's move to license drugs that were ...
Lobbying depends on cultivating personal relationships over many years. Photo: Lobbyist Tony Podesta (left) with former Senator Kay Hagan (center) and her husband.. Generally, lobbyists focus on trying to persuade decision-makers: Congress, executive branch agencies such as the Treasury Department and the Securities and Exchange Commission, [16] the Supreme Court, [17] and state governments ...
United States Army Materiel Command (AMC) Army Research, Development and Engineering Command (RDECOM) Army Research Laboratory (ARL) Army Armament Research, Development and Engineering Center (ARDEC) Engineer Research and Development Center (ERDC) U.S. Army Test and Evaluation Command (ATEC) Army Medical Research and Material Command (USAMRMC)
800-290-4726 more ways to reach us. Sign in. Mail. 24/7 Help. ... Big Pharma ads, lobbying hurt seniors with prescription prices | Opinion ... RI's health care system is 'in critical condition ...
In the 1990s, the US medical biological defense research effort (part of the U.S. Army's Biological Defense Research Program [BDRP]) was concentrated at USAMRIID at Fort Detrick. The army maintained state-of-the-art containment laboratory facilities there, with more than 10,000 ft2 of BSL-4 and 50,000 ft2 of BSL-3 laboratory space.
It will also join a lawsuit filed by Merck and industry lobbying firm PhRMA, officials said Thursday. The filing due date for the briefs are Sept. 18 for the Merck lawsuit and Oct. 6 for PhRMA.